Cover Image
Market Research Report

Semi-Permeable Films - Medical Devices Pipeline Assessment, 2017

Published by GlobalData Product code 333944
Published Content info 71 Pages
Immediate Delivery Available
Price
Back to Top
Semi-Permeable Films - Medical Devices Pipeline Assessment, 2017
Published: May 3, 2017 Content info: 71 Pages
Description

GlobalData's Medical Devices sector report, "Semi-Permeable Films - Medical Devices Pipeline Assessment, 2017" provides an overview of Semi-Permeable Films currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Semi-Permeable Films pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Semi-Permeable Films under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Semi-Permeable Films and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Semi-Permeable Films under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Semi-Permeable Films Overview 5

3 Products under Development 6

  • 3.1 Semi-Permeable Films - Pipeline Products by Stage of Development 6
  • 3.2 Semi-Permeable Films - Pipeline Products by Segment 7
  • 3.3 Semi-Permeable Films - Pipeline Products by Territory 8
  • 3.4 Semi-Permeable Films - Pipeline Products by Regulatory Path 9
  • 3.5 Semi-Permeable Films - Pipeline Products by Estimated Approval Date 10

4 Semi-Permeable Films - Pipeline Products under Development by Companies 11

  • 4.1 Semi-Permeable Films Companies - Pipeline Products by Stage of Development 11
  • 4.2 Semi-Permeable Films - Pipeline Products by Stage of Development 11

5 Semi-Permeable Films Companies and Product Overview 12

  • 5.1 BioTime Inc Company Overview 12
    • 5.1.1 BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 12
  • 5.2 Covalon Technologies Ltd Company Overview 13
    • 5.2.1 Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.3 Imbed Biosciences Inc Company Overview 19
    • 5.3.1 Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.4 Leiden University Company Overview 20
    • 5.4.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.5 Stratpharma AG Company Overview 21
    • 5.5.1 Stratpharma AG Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.6 ULURU Inc Company Overview 22
    • 5.6.1 ULURU Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.7 Vancive Medical Technologies Company Overview 23
    • 5.7.1 Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 23

6 Semi-Permeable Films- Recent Developments 24

  • 6.1 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director 24
  • 6.2 Apr 06, 2017: BioTime Forms New Subsidiary AgeX Therapeutics to Develop its Programs Focused on Human Aging 24
  • 6.3 Apr 05, 2017: Clinical Effectiveness of Covalon's ColActive Plus to be Presented at SAWC Spring Meeting 25
  • 6.4 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System 26
  • 6.5 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 27
  • 6.6 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 28
  • 6.7 Mar 16, 2017: BioTime Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Accomplishments 29
  • 6.8 Feb 21, 2017: BioTime Reports Pro Forma Gain on Deconsolidation of OncoCyte Subsidiary 31
  • 6.9 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 32
  • 6.10 Feb 09, 2017: Smith & Nephew: Directorate Change 37
  • 6.11 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 37
  • 6.12 Feb 07, 2017: BioTime Appoints Industry Veteran, Stephana Patton, Ph.D., J.D., as General Counsel 38
  • 6.13 Jan 30, 2017: Covalon Posts Record First Quarter Financial Results 39
  • 6.14 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 40
  • 6.15 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 41
  • 6.16 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 41
  • 6.17 Jan 03, 2017: Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth 42
  • 6.18 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 43
  • 6.19 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 44
  • 6.20 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 45
  • 6.21 Nov 03, 2016: BioTime Reports Third Quarter Results and Recent Clinical Progress 46
  • 6.22 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 48
  • 6.23 Oct 01, 2016: Imbed Bio Recruits Jeffrey Dalsin To Lead Product Development 48
  • 6.24 Sep 16, 2016: Covalon to Showcase IV Clear to Pediatric Specialists at the Association for Vascular Access Annual Meeting 49
  • 6.25 Sep 09, 2016: Imbed Biosciences Secures ISO 13485:2003 Certification 50
  • 6.26 Aug 19, 2016: Covalon Announces Third Quarter Financial Results 50
  • 6.27 Aug 15, 2016: BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative Medicine 51
  • 6.28 Aug 09, 2016: Covalon Wins Another $3.5 Million Twelve Month Contract to Supply IV Clear Vascular Access Dressings to Saudi Arabia 51
  • 6.29 Aug 09, 2016: BioTime Reports Second Quarter Results and Recent Corporate Accomplishments 52
  • 6.30 Aug 05, 2016: UW-Madison Spinoff Gets FDA OK for Bacteria-Killing Wound Dressing 54
  • 6.31 Aug 05, 2016: Imbed Receives FDA Clearance for Bacteria-Killing Wound Dressing 55
  • 6.32 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 56
  • 6.33 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 60
  • 6.34 Jul 11, 2016: 3M Announces New Leadership Appointments 60
  • 6.35 Jun 21, 2016: entrotech life sciences launches ChloraDerm IV Securement portfolio 61
  • 6.36 Jun 15, 2016: Covalon Signs Distribution Agreement with Medline 61
  • 6.37 Jun 07, 2016: Covalon Announces Participation in Ontario Government's Medical Trade Mission to Mexico 62
  • 6.38 Jun 06, 2016: entrotech life sciences appoints former U.S. Surgeon General, Dr. Kenneth Moritsugu as Medical Director 63
  • 6.39 Jun 01, 2016: Covalon Announces Further Expansion in the Middle East 63
  • 6.40 May 30, 2016: Covalon Announces Second Quarter Financial Results 64
  • 6.41 May 10, 2016: BioTime Reports First Quarter Results and Recent Corporate Accomplishments 65

7 Appendix 68

  • 7.1 Methodology 68
  • 7.2 About GlobalData 71
  • 7.3 Contact Us 71
  • 7.4 Disclaimer 71

List of Tables

1.1 List of Tables

  • Table 1: Semi-Permeable Films - Pipeline Products by Stage of Development 6
  • Table 2: Semi-Permeable Films - Pipeline Products by Segment 7
  • Table 3: Semi-Permeable Films - Pipeline Products by Territory 8
  • Table 4: Semi-Permeable Films - Pipeline Products by Regulatory Path 9
  • Table 5: Semi-Permeable Films - Pipeline Products by Estimated Approval Date 10
  • Table 6: Semi-Permeable Films Companies - Pipeline Products by Stage of Development 11
  • Table 7: Semi-Permeable Films - Pipeline Products by Stage of Development 11
  • Table 8: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 12
  • Table 9: BioTime Films - Product Status 12
  • Table 10: BioTime Films - Product Description 12
  • Table 11: Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 12: ColActive Plus Ag - Product Status 14
  • Table 13: ColActive Plus Ag - Product Description 15
  • Table 14: IV Clear - Product Status 15
  • Table 15: IV Clear - Product Description 16
  • Table 16: MediClear PreOp - Product Status 16
  • Table 17: MediClear PreOp - Product Description 17
  • Table 18: SurgiClear Antimicrobial Clear Silicone Surgical Dressing With Chlorhexidine And Silver - Product Status 17
  • Table 19: SurgiClear Antimicrobial Clear Silicone Surgical Dressing With Chlorhexidine And Silver - Product Description 18
  • Table 20: Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 21: Microlyte Ag - Product Status 19
  • Table 22: Microlyte Ag - Product Description 19
  • Table 23: Leiden University Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 24: Skin Barrier Repair Biofilm - Product Status 20
  • Table 25: Skin Barrier Repair Biofilm - Product Description 20
  • Table 26: Stratpharma AG Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 27: StrataXRT - Product Status 21
  • Table 28: StrataXRT - Product Description 21
  • Table 29: ULURU Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 30: Altrazeal exSALT - Product Status 22
  • Table 31: Altrazeal exSALT - Product Description 22
  • Table 32: Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 33: BeneHold CHG Adhesive - Surgical Incise Film - Product Status 23
  • Table 34: BeneHold CHG Adhesive - Surgical Incise Film - Product Description 23
  • Table 35: Glossary 70

List of Figures

1.2 List of Figures

  • Figure 1: Semi-Permeable Films - Pipeline Products by Stage of Development 6
  • Figure 2: Semi-Permeable Films - Pipeline Products by Segment 7
  • Figure 3: Semi-Permeable Films - Pipeline Products by Territory 8
  • Figure 4: Semi-Permeable Fil
Back to Top